N2OFF, Inc. (NITO)
Automate Your Wheel Strategy on NITO
With Tiblio's Option Bot, you can configure your own wheel strategy including NITO - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol NITO
- Rev/Share 0.0002
- Book/Share 0.0092
- PB 271.4688
- Debt/Equity 0.126
- CurrentRatio 4.206
- ROIC -0.4053
- MktCap 2449295.0
- FreeCF/Share -0.003
- PFCF -0.8739
- PE -345.5378
- Debt/Assets 0.102
- DivYield 0
- ROE -1.2001
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
N2OFF: MitoCareX Identifies Hit Compounds and Targets Preclinical Candidate Nomination
Published: November 18, 2025 by: GlobeNewsWire
Sentiment: Neutral
Neve Yarak, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) (“N2OFF”), a cleantech company investing in solar energy assets based on the RTB (Ready to Build) business model, following the completion of its acquisition of MitoCareX Bio Ltd., today shared an update from the Chief Executive Officer of MitoCareX, Dr. Alon Silberman, including a shareholder letter that outlines the company's strategic direction, near-term milestones, and development plans within the rapidly expanding precision oncology market.
Read More
N2OFF Completed Merger with Cancer Drug Discovery Company Targeting Tough-to-Treat Pancreatic and Lung Cancers
Published: October 30, 2025 by: GlobeNewsWire
Sentiment: Neutral
Neve Yarak, Israel, Oct. 30, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a cleantech company investing in solar energy assets based on the RTB (Ready to Build) business model, recently announced the closing of the merger with MitoCareX Bio Ltd. ("MitoCareX"), a biotech company focused on drug discovery targeting cancer therapeutics, with a range of other potential diseases and disorders, through targeting the mitochondrial SLC25 protein family.
Read More
N2OFF via Solterra Expands European Footprint with Entry into Fourth Project – a Battery Storage Venture in Poland
Published: May 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
N2OFF to take part in financing a 35MW/140MWh planned Battery Energy Storage System project in Poland Neve Yarak, Israel, May 09, 2025 (GLOBE NEWSWIRE) -- N2OFF, Inc.(NASDAQ: NITO) (FSE:80W) (“N2OFF” and the “Company”), a clean tech company engaged in sustainable solutions for energy and innovation for agri- tech, announced Solterra's entry into the Polish renewable energy market by participating in the financing of a Battery Energy Storage System (BESS) project in Poland. The project, currently planned at 35MW/140MWh, represents a significant step in expanding Solterra's large-scale energy storage solutions in the region.
Read More
N2OFF and Solterra Announce the Closing of a Definitive Agreement to Develop 196 MWp Battery Storage Projects in Italy
Published: February 24, 2025 by: GlobeNewsWire
Sentiment: Neutral
CURRENTLY N2OFF IS COMMITTED TO invest up to € 4.4 million in projects located in Germany and Italy for total capacity of over 300 MW
Read More
About N2OFF, Inc. (NITO)
- IPO Date 2010-11-12
- Website https://www.n2off.htmline.com
- Industry Agricultural Inputs
- CEO David Palach
- Employees 3